Danielle Laskowitz

Moffitt Cancer Center

Papers

1

Total Citations

21

H-Index

1

About

Danielle Laskowitz is a leading clinical researcher in gastrointestinal oncology, with a focused expertise in the multidisciplinary management of locally advanced rectal adenocarcinoma. Her work centers on optimizing treatment sequences, intensification strategies, and the emerging paradigm of rectal organ preservation—a critical area aimed at improving quality of life for patients. Laskowitz’s most-cited paper, a 2021 study detailing the case of a 68-year-old man with a 6-cm rectal mass, exemplifies her commitment to translating complex clinical scenarios into actionable treatment frameworks. This work, with 21 citations, has helped shape discussions around non-surgical approaches and intensified neoadjuvant therapies. Beyond this, her contributions underscore the importance of personalized care in rectal cancer, balancing oncologic outcomes with functional preservation. Laskowitz’s research continues to influence how clinicians sequence chemoradiation, total neoadjuvant therapy, and watch-and-wait protocols, making her a notable voice in the push toward less invasive, yet equally effective, treatment paradigms. Her work is essential reading for trainees and specialists navigating the evolving landscape of rectal cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation
21 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Moffitt Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago